<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Gastroenterol</journal-id><journal-title>BMC Gastroenterology</journal-title><issn pub-type="epub">1471-230X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">16638132</article-id><article-id pub-id-type="pmc">1508152</article-id><article-id pub-id-type="publisher-id">1471-230X-6-15</article-id><article-id pub-id-type="doi">10.1186/1471-230X-6-15</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Deibert</surname><given-names>Peter</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>peter.deibert@uniklinik-freiburg.de</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Allgaier</surname><given-names>Hans-Peter</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>HAllgaier@titisee.helios-kliniken.de</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Loesch</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>loesch-hilger@gmx.de</email></contrib><contrib id="A4" contrib-type="author"><name><surname>M&#x000fc;ller</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>c.mueller@kliniken-es.de</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Olschewski</surname><given-names>Manfred</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>mol@imbi.uni-freiburg.de</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Hamm</surname><given-names>Hinrich</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>h.hamm@asklepios.de</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Maier</surname><given-names>Klaus-Peter</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>kp.maier@kliniken-es.de</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Blum</surname><given-names>Hubert Erich</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>hubert.blum@uniklinik-freiburg.de</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Medicine VII, University Freiburg, Germany</aff><aff id="I2"><label>2</label>Department of Medicine II, University Freiburg, , Germany</aff><aff id="I3"><label>3</label>Department of Medical Biometry, University Freiburg, , Germany</aff><aff id="I4"><label>4</label>Helios Hospital, Department of Internal Medicine, Titisee-Neustadt, Germany</aff><aff id="I5"><label>5</label>Liver Center, City Hospital Esslingen, Germany</aff><aff id="I6"><label>6</label>Asklepios Klinik, Dept. of Internal Medicine and Lung Clinic, Westerland, Germany</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>25</day><month>4</month><year>2006</year></pub-date><volume>6</volume><fpage>15</fpage><lpage>15</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-230X/6/15"/><history><date date-type="received"><day>7</day><month>2</month><year>2006</year></date><date date-type="accepted"><day>25</day><month>4</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Deibert et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Deibert et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Deibert
               Peter
               
               peter.deibert@uniklinik-freiburg.de
            </dc:author><dc:title>
            Hepatopulmonary syndrome in patients with chronic liver disease: role of pulse oximetry
         </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Gastroenterology 6(1): 15-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-230X(2006)6:1&#x0003c;15&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-230X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Hepatopulmonary syndrome (HPS) is a rare complication of liver diseases of different etiologies and may indicate a poor prognosis. Therefore, a simple non-invasive screening method to detect HPS would be highly desirable. In this study pulse oximetry was evaluated to identify patients with HPS.</p></sec><sec sec-type="methods"><title>Methods</title><p>In 316 consecutive patients with liver cirrhosis (n = 245), chronic hepatitis (n = 69) or non-cirrhotic portal hypertension (n = 2) arterial oxygen saturation (SaO<sub>2</sub>) was determined using a pulse oximeter. In patients with SaO<sub>2 </sub>&#x02264;92% in supine position and/or a decrease of &#x02265;4% after change from supine to upright position further diagnostic procedures were performed, including contrast-enhanced echocardiography and perfusion lung scan.</p></sec><sec><title>Results</title><p>Seventeen patients (5.4%) had a pathological SaO<sub>2</sub>. Four patients (1.3%) had HPS. HPS patients had a significant lower mean SaO<sub>2 </sub>in supine (89.7%, SD 5.4 <italic>vs</italic>. 96.0%, SD 2.3; p = 0.003) and upright position (84.3%, SD 5.0 <italic>vs</italic>. 96.0%, SD 2.4; p = 0.001) and had a lower mean PaO<sub>2 </sub>(56.2 mm Hg, SD 15.2 <italic>vs</italic>. 71.2 mm Hg, SD 20.2; p = 0.02) as compared to patients without HPS. The mean &#x00394;SaO<sub>2 </sub>(difference between supine and upright position) was 5.50 (SD 7) in HPS patients compared to non-HPS patients who showed no change (p = 0.001). There was a strong correlation between shunt volume and the SaO<sub>2 </sub>values (R = -0.94).</p></sec><sec><title>Conclusion</title><p>Arterial SaO<sub>2 </sub>determination in supine and upright position is a useful non-invasive screening test for HPS and correlates well with the intrapulmonary shunt volume.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>In 1884 Fl&#x000fc;ckiger first described a women with liver cirrhosis, cyanosis, and digital clubbing [<xref ref-type="bibr" rid="B1">1</xref>]. The term 'hepatopulmonary syndrome', the triad of liver disease, an increased alveolar-arterial gradient while breathing room air, and evidence of intrapulmonary vascular dilatations, was coined in 1977 by Kennedy and Knudson [<xref ref-type="bibr" rid="B2">2</xref>]. These vascular abnormalities predominate in the lower lung fields. As gravity induces increased blood flow to the lower lung fields hypoxemia is increased when changing from supine to upright position. Mild hypoxemia occurs in approximately one third of all patients with chronic liver disease and often is multifactorial [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>], because other cardiopulmonary abnormalities (e.g., pleural effusions, ascites) are common in these patients and may coexist with HPS. The special qualities of HPS are platypnea [<xref ref-type="bibr" rid="B5">5</xref>], defined as dyspnoe induced by the upright position and relieved by recumbency and orthodeoxia [<xref ref-type="bibr" rid="B6">6</xref>], defined as arterial deoxygenation induced by the upright position and relieved by recumbency. Although these phenomena are not pathognomonic for HPS, they strongly suggest this diagnosis in the setting of liver dysfunction [<xref ref-type="bibr" rid="B7">7</xref>].</p><p>The aim of our open prospective study was to evaluate arterial oxygen saturation (SaO<sub>2</sub>) as a non-invasive screening test for HPS in patients with chronic liver disease or non-cirrhotic portal hypertension. Furthermore, clinical manifestations of HPS were analyzed. Further we wanted to find out, whether it was possible to estimate the shunt volume by this non-invasive procedure.</p></sec><sec sec-type="methods"><title>Methods</title><p>316 in- and outpatients with liver cirrhosis (n = 245), chronic hepatitis (n = 69) or non-cirrhotic portal hypertension (n = 2) were enrolled in a prospective study.</p><p>The clinical characteristics of the patients participating in the study are summarized in Table <xref ref-type="table" rid="T1">1</xref>. The majority of patients were male (194/316). The mean age was 54.5 years (SD 12.9). The etiology of chronic liver disease was alcohol use in 51%, chronic hepatitis B in 15% and chronic hepatitis C in 22%. Rare aetiologies were hemochromatosis, Wilson's disease, primary biliary cirrhosis (PBC) or autoimmune hepatitis. Two patients had non-cirrhotic portal hypertension due to nodular regenerative hyperplasia (NRH) and portal vein thrombosis of unknown origin, respectively.</p><p>The diagnosis of liver cirrhosis was based on clinical, biochemical and ultrasound criteria. In 69/245 patients liver cirrhosis was confirmed histologically. 71 patients had chronic hepatitis or non-cirrhotic portal hypertension without evidence for cirrhosis. The patients with liver cirrhosis were classified according to the Child-Pugh classification [<xref ref-type="bibr" rid="B8">8</xref>] as follows: A: 36.3%, B: 42.5% and C: 21.2%.</p><p>Measurement of SaO<sub>2 </sub>was performed with a portable pulse oximeter (Onyx, Nonin, USA or Sirecrust 610, Siemens, Germany). In all patients, the measurements were performed at ambient O<sub>2 </sub>partial pressure in supine position. A second reading was taken after 10 minutes in upright position. A pathological test result was defined as: (i) SaO<sub>2 </sub>&#x02264;92% in supine position, (ii) a decrease in SaO<sub>2 </sub>of &#x02265;4% after change from supine to the upright position (&#x00394;SaO<sub>2</sub>) [<xref ref-type="bibr" rid="B9">9</xref>]. In patients with a pathological test the following additional studies were performed: chest x-ray, pulmonary function tests, transthoracic contrast-enhanced echocardiography (CEE) and perfusion lung scanning.</p><p>For CEE, 10 ml of 5.5% oxypolygelatine (Gelifundol<sup>&#x000ae;</sup>, Biotest Pharma, Dreieich, Germany) were injected intravenously. This technique is based on the formation of microbubbles that are normally retained by the pulmonary capillaries and therefore do not appear in the left heart [<xref ref-type="bibr" rid="B10">10</xref>]. In the presence of intrapulmonary or intracardiac right-to-left-shunts, however, microbubbles will opacify the left heart. Depending on the time elapsing between contrast medium injection and the appearance of microbubbles in the left heart intracardiac and intrapulmonary shunts can be discriminated. In case of intracardiac right-to-left shunts, microbubbles appear within three heart beats after the appearance in the right chambers. In patients with intrapulmonary shunts contrast medium appears in the left heart after four to six heart beats [<xref ref-type="bibr" rid="B11">11</xref>]. To date, there is no satisfactory shunt calculation with the CEE technique [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p><p>Perfusion lung scanning was performed with technetium 99 m (99 mTc)-labeled macroaggregated albumin to directly demonstrate intrapulmonary vascular shunts [<xref ref-type="bibr" rid="B14">14</xref>]. Albumin macroaggregates are larger than 20 &#x003bc;m in diameter and are normally trapped in the pulmonary capillaries (diameter 8 to 15 &#x003bc;m). Uptake of radionuclide by kidney, brain etc., therefore, indicates pathological passage through intrapulmonary or intracardiac shunts. The extrapulmonary shunt fraction, assuming that 13% of the cardiac output is delivered to the brain, was calculated using the geometric mean of technetium counts in the brain and lung as described by Abrams and others [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. The shunt fraction was considered positive if the value was &#x0003e;6%.</p><p>The diagnosis of HPS was established when the following criteria were fulfilled: arterial deoxygenation (measured by a SaO<sub>2 </sub>&#x02264;92 or a &#x00394;SaO<sub>2</sub>of &#x02265;4%), positive CEE and positive perfusion lung scanning using according to the definition of the European Task Force [<xref ref-type="bibr" rid="B16">16</xref>].</p><sec><title>Statistical analysis</title><p>In our study, quantitative variables are presented as means and standard deviations (SD), qualitative variables as absolute and relative frequencies. Clinical characteristics of HPS patients were compared to those of patients without HPS by a Wilcoxon rank test for quantitative and Fisher's exact test for dichotomous variables. In HPS patients the relationship between CEE and shunt volume was determined by linear regression analysis and estimation of the Pearson correlation coefficient. All tests were two-sided with a p-value of &#x0003c;0.05. Data analysis was performed with the Statistical Analysis System (SAS Institute Inc., Cary, NC, USA). The study protocol was approved by the ethics committee of the Albert-Ludwigs-University of Freiburg. Written informed consent was obtained from all the participants.</p></sec></sec><sec><title>Results</title><p>Among the 316 patients seventeen patients (5.4%) had a pathological SaO<sub>2 </sub>according to the criteria described above. These patients underwent CEE analyses (n = 17), perfusion lung scanning (n = 13) and pulmonary function tests (n = 17). On the basis of these analyses 4 patients with HPS were identified. In the 13 non-HPS patients 11 patients had a SaO<sub>2 </sub>&#x0003c; 92 but no remarkable change in upright position and two had a SaO<sub>2 </sub>&#x0003e; 92 combined with a drop of &#x0003e;= 4 in upright position. CEE demonstrated in all four HPS patients the appearance of microbubbles in the left heart 4&#x02013;6 heart cycles after the appearance in the right heart. In one additional patient microbubbles appeared within three heart beats due to an atrial septum defect. CEE was well tolerated by all patients.</p><p>The mean SaO<sub>2 </sub>levels in patients with HPS as compared to patients without HPS were significantly lower in supine (89.7%, SD 5.4 <italic>vs</italic>. 96.0%, SD 2.3, p = 0.0034) and upright position (84.3%, SD 5.0 <italic>vs</italic>. 96.0%, SD 2.4, p = 0.0006, Table <xref ref-type="table" rid="T2">2</xref>). Most importantly, not all HPS patients had a pathological SaO<sub>2 </sub>in the supine position but all showed a significant SaO<sub>2 </sub>decrease after changing from supine to upright position (Fig. <xref ref-type="fig" rid="F1">1</xref>). The mean &#x00394;SaO<sub>2 </sub>in the HPS patients was 5.50 (SD 7) compared to non-HPS patients, who showed no change (p = 0.001). In the 13 patients without HPS the pathologically reduced SaO<sub>2 </sub>was caused by chronic obstructive lung disease (n = 9), large volume ascites, atrial septum defect, the fall of SaO<sub>2 </sub>with normal initial value was seen in a patient with large volume ascites and a patient with portopulmonary hypertension, respectively.</p><p>In 13/17 patients with a pathological SaO<sub>2</sub>, including the 4 HPS patients, a perfusion lung scanning was performed. In all HPS patients extrapulmonary radionuclide uptake was detected. The shunt volume was estimated to be between 7% and 34% (mean 20%) of the cardiac output. The patients without HPS showed no extrapulmonary radionuclide uptake. The shunt volume in the 4 HPS patients correlated very well with the SaO<sub>2 </sub>values (r = -0.94, Fig. <xref ref-type="fig" rid="F2">2</xref>) and with the pO<sub>2 </sub>values (r = -0.69, Fig. <xref ref-type="fig" rid="F3">3</xref>).</p><p>HPS patients showed pronounced hypoxemia (mean PaO<sub>2 </sub>= 56.2 mm Hg, SD 15.2) in capillary blood gas analyses under ambient O<sub>2 </sub>partial pressure compared to the patients without HPS but a SaO<sub>2 </sub>below 92% (mean PaO<sub>2 </sub>= 78.1 mm Hg, SD 10.7).</p><p>In all 17 patients with pathological SaO<sub>2</sub>, pulmonary function tests were performed. CO diffusion capacity (HPS: mean 42%, SD 4.1 <italic>vs</italic>. non-HPS: mean 75.3%, SD 17.7; p = 0.038) and residual volume (2.0 l, SD 0.75 <italic>vs</italic>. 3.3 l, SD 1.2; p = 0.036) were significantly reduced in HPS patients. Vital capacity, pCO<sub>2</sub>, base excess, HCO<sub>3 </sub>and pH were not significantly different in patients with and without HPS, although there was a trend for FEV1 being lower in non-HPS patients.</p><p>In HPS patients there was a trend towards higher mean respiration and pulse rate as well as a lower mean systolic and diastolic blood pressure. Cyanosis, dyspnea and digital clubbing were more frequent in HPS patients. The frequency of skin manifestations of chronic liver disease, e.g., spider naevi, palmar erythema, and ascites or hepatic encephalopathy were not different between patients with and without HPS.</p><p>Hematologic analyses showed a trend towards higher hemoglobin (14.1 g/dl, SD 2.2 <italic>vs</italic>. 12.5 g/dl, SD 2.2) and hematocrit values (42.5%, SD 6.6 <italic>vs</italic>. 37.5%, SD 12.1) in patients with HPS compared to patients without HPS. Clinical chemistry (bilirubin, albumin, prothrombin time) and Child-Pugh-Score were not different between patients with and without HPS. Chest radiographs showed no abnormalities, such as increased interstitial markings [<xref ref-type="bibr" rid="B17">17</xref>], in either group of patients.</p></sec><sec><title>Discussion</title><p>Hypoxemia is common in patients with chronic liver disease [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. A rare cause is HPS that may cause dyspnea, platypnea, and orthodeoxia and poor prognosis [<xref ref-type="bibr" rid="B19">19</xref>]. Because other abnormalities, (e.g., hydrothorax, ascites) may coexist in HPS patients and contribute to respiratory insufficiency, measurement of a lowered paO<sub>2 </sub>or SaO<sub>2 </sub>alone is not sufficient to make the diagnosis of HPS. The diagnostic criteria of HPS include liver disease, hypoxemia with a paO<sub>2</sub>&#x0003c;70 mmHg and evidence for intrapulmonary vascular dilation. This study was conducted to evaluate pulse oximetry as a non-invasive screening for HPS in patients with chronic liver disease. Therefore, arterial blood gas analyses were only obtained from patients with a SaO<sub>2 </sub>below the threshold value of 92% or a decrease in SaO<sub>2 </sub>of &#x02265;4% after change from supine to the upright position (&#x00394;SaO<sub>2</sub>). In liver transplant candidates a threshold level of SaO<sub>2 </sub>of 94% detected all subjects with an arterial pO<sub>2 </sub>&#x0003c;60 mm Hg [<xref ref-type="bibr" rid="B20">20</xref>]. A patient with a SaO<sub>2 </sub>&#x0003e;92% and no significant decrease in this value in the upright position is unlikely to have a paO<sub>2 </sub>&#x0003c;70 mm Hg and pulmonary shunts without these being detected by our screening. There may be a small subgroup of patients with positive contrast echocardiograms and essentially normal or slightly changed oxygenation due to form fruste or subclinical HPS. We cannot determine how many patients we missed to detect due to a lack of a position change in SaO<sub>2</sub>. The incidence and clinical significance of these forms of HPS is not clear. However, patients with clinically apparent HPS have a significant mortality and have to be identified, because HPS is an indication and not a contraindication for liver transplantation [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B23">23</xref>]. Our intention was not to determine the true prevalence of HPS including minor forms but to detect clinically relevant cases by a simple screening algorithm.</p><p>In our study of 316 patients almost 80% had liver cirrhosis; the remaining patients had chronic hepatitis or non-cirrhotic portal hypertension. The majority of patients had compensated liver function. Only 17 patients (5.4%) had a pathological SaO<sub>2 </sub>or a decrease in SaO<sub>2 </sub>of &#x02265;4%. This is a relatively small percentage compared to other study populations, such as liver transplant candidates [<xref ref-type="bibr" rid="B12">12</xref>]. Four patients (1.3%) in our prospective study met the diagnostic criteria for HPS. 11 patients without HPS had a SaO<sub>2 </sub>&#x02264;92 and two a &#x00394;SaO<sub>2 </sub>of &#x02265;4%.</p><p>Data regarding the incidence of HPS are limited and estimations of prevalence vary as different definitions for HPS are used. Based on the prospective design of our study, the 1.3% prevalence of significant HPS appears realistic in patients with chronic liver disease.</p><p>HPS patients in our study were younger than patients without HPS. Similarly, Rydell and Hoffbauer in 1956 described a 17-year old patient with liver cirrhosis and dilated pulmonary vessels and arteriovenous fistulas, found at autopsy [<xref ref-type="bibr" rid="B24">24</xref>]. At the same time, Hales described some very young patients with similar pulmonary findings and liver disease [<xref ref-type="bibr" rid="B25">25</xref>]. Even in childhood HPS may occur [<xref ref-type="bibr" rid="B26">26</xref>].</p><p>Two of our 4 HPS patients had liver cirrhosis due to chronic viral hepatitis. One of these patients also had a hepatocellular carcinoma. The two other HPS patients had portal hypertension due to NRH and portal vein thrombosis of unknown origin, respectively. Both acute [<xref ref-type="bibr" rid="B27">27</xref>] and chronic [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>] liver diseases have been associated with HPS. Most commonly, HPS appears in patients with chronic liver diseases progressing to liver cirrhosis, especially in cryptogenic cirrhosis, alcoholic cirrhosis, PBC and chronic viral hepatitis B or C. However, the occurrence of HPS in patients with noncirrhotic portal hypertension [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B30">30</xref>], as in 2 of our HPS patients, suggests that cirrhosis is not a prerequisite for the development of HPS.</p><p>In our patients there was no correlation between the occurrence of HPS and liver function tests (bilirubin, albumin and prothrombin time), similar to previous findings [<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. Different from other studies [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>] we found no association between spider naevi or other skin manifestations of liver disease and HPS. The most impressive physical findings in HPS patients were cyanosis, dyspnea and digital clubbing, which were more frequent in HPS patients than in non-HPS patients. The pathogenesis of digital clubbing is not completely understood. One hypothesis is based on the fact that megakaryocytes and platelet aggregates are normally retained by the lung capillaries. In patients with a right-to-left-shunts megakaryocytes reach the digital capillaries [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>], there releasing platelet derived growth factor (PDGF). PDGF is known to cause increased capillary permeability and proliferation of fibroblasts that may result in clubbing [<xref ref-type="bibr" rid="B36">36</xref>].</p><p>Since hypoxemia and orthodeoxia are not pathognomic for HPS, CEE is necessary to discriminate between intrapulmonary or intracardiac right-to-left shunts. All patients with pathological SaO<sub>2 </sub>or elevated &#x00106;SaO<sub>2 </sub>underwent CEE in our study. In 5 patients microbubbles appeared in the left heart. In one patient this was caused by an atrial septum defect. In the remaining four patients HPS was diagnosed, because microbubbles appeared already after 4&#x02013;6 heart beats in the left heart.</p><p><sup>99m</sup>Tc-labeled macroaggregated albumin scanning is another technique to detect and to quantify intrapulmonary vascular shunts [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. In all 4 HPS patients extrapulmonary radionuclide uptake confirmed the existence of intrapulmonary shunts. The estimated shunt volume was between 7% and 34% (mean 20%) of the cardiac output and correlated well with the SaO<sub>2 </sub>(r = -0.94) and the arterial pO<sub>2 </sub>(r = -0.69). Abrams and coworkers described a similar correlation between arterial pO<sub>2 </sub>and shunt volume (r = -0.73) however, SaO<sub>2 </sub>was not determined [<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Patients with end-stage liver disease may have various pulmonary abnormalities, including restrictive and obstructive lung disease. HPS patients tend to have a decreased CO diffusion capacity with normal pulmonary capacity and expiratory flow rates [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B37">37</xref>]. These findings were confirmed in our study.</p></sec><sec><title>Conclusion</title><p>Combined SaO<sub>2 </sub>determination in supine and upright position using a pulse oximeter is a simple test to identify HPS in patients with chronic liver disease or noncirrhotic portal hypertension. In our prospective clinical study only in 4 out of 316 patients (1.3%) with chronic liver disease had HPS. Shunt volumes can be quantified by lung perfusion scanning and correlate better with the values of SaO<sub>2 </sub>than pO<sub>2</sub>. This correlation may allow an estimation of the severity of the shunt volume without performing lung perfusion scanning. In clinical practice determination of arterial oxygen saturation with a pulse oximeter can be used as a simple screening test and may help to identify more HPS patients with the aim to study the pathogenesis and to develop therapeutic strategies.</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>Peter Deibert is the corresponding author of the study. Peter Deibert, Hans-Peter Allgaier and Stefanie Loesch took part in designing the study, performed the data analyses and drafted the manuscript. Claudia M&#x000fc;ller performed data acquisition in a considerable number of patients and helped to write the manuscript. Manfred Olschewski supported data analyses. Hinrich Hamm, Klaus-Peter Maier and Hubert Erich Blum supervised the study and gave critical comments to the manuscript. All authors have read and approved the final version of the manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-230X/6/15/prepub"/></p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fl&#x000fc;ckiger</surname><given-names>M</given-names></name></person-group><article-title>Vorkommen von trommelschlegelf&#x000f6;rmigen Fingerendphalangen ohne chronische Ver&#x000e4;nderungen an den Lungen oder am Herzen</article-title><source>Wien Med Wochenschr</source><year>1884</year><volume>34</volume><fpage>1457</fpage><lpage>1458</lpage></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>TC</given-names></name><name><surname>Knudson</surname><given-names>RJ</given-names></name></person-group><article-title>Exercise-aggravated hypoxemia and orthodeoxia in cirrhosis</article-title><source>Chest</source><year>1977</year><volume>72</volume><fpage>305</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">891282</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sherlock</surname><given-names>S</given-names></name></person-group><article-title>The liver-lung interface</article-title><source>Semin Resp Med</source><year>1988</year><volume>9</volume><fpage>253</fpage></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>N</given-names></name><name><surname>Yasumoto</surname><given-names>K</given-names></name><name><surname>Inokuchi</surname><given-names>K</given-names></name></person-group><article-title>Arterial hypoxemia in patients with hepatic cirrhosis</article-title><source>Am J Med Sci</source><year>1984</year><volume>287</volume><fpage>10</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">6428227</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>M</given-names></name><name><surname>Robin</surname><given-names>ED</given-names></name></person-group><article-title>Platypnea (diffuse zone I phenomenon?)</article-title><source>N Engl J Med</source><year>1969</year><volume>281</volume><fpage>1347</fpage><lpage>1348</lpage><pub-id pub-id-type="pmid">5355439</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Robin</surname><given-names>ED</given-names></name><name><surname>Laman</surname><given-names>D</given-names></name><name><surname>Horn</surname><given-names>BR</given-names></name><name><surname>Theodore</surname><given-names>J</given-names></name></person-group><article-title>Platypnea related to orthodeoxia caused by true vascular lung shunts</article-title><source>N Engl J Med</source><year>1976</year><volume>294</volume><fpage>941</fpage><lpage>943</lpage><pub-id pub-id-type="pmid">1256486</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arguedas</surname><given-names>MR</given-names></name><name><surname>Fallon</surname><given-names>MB</given-names></name><name><surname>Fallon</surname><given-names>MB</given-names></name></person-group><article-title>Hepatopulmonary syndrome</article-title><source>Curr Treat Options Gastroenterol</source><year>2005</year><volume>8</volume><fpage>451</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">16313862</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pugh</surname><given-names>RNH</given-names></name><name><surname>Murray-Lyon</surname><given-names>IM</given-names></name><name><surname>Dawson</surname><given-names>JL</given-names></name></person-group><article-title>Transsection of the esophagus for bleeding oesophageal varices</article-title><source>Brit J Surg</source><year>1973</year><volume>60</volume><fpage>646</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">4541913</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whyte</surname><given-names>MK</given-names></name><name><surname>Hughes</surname><given-names>JM</given-names></name><name><surname>Peters</surname><given-names>AM</given-names></name><name><surname>Ussov</surname><given-names>W</given-names></name><name><surname>Patel</surname><given-names>S</given-names></name><name><surname>Burroughs</surname><given-names>AK</given-names></name></person-group><article-title>Analysis of intrapulmonary right to left shunt in the hepatopulmonary syndrome</article-title><source>J Hepatol</source><year>1998</year><volume>29</volume><fpage>85</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">9696496</pub-id><pub-id pub-id-type="doi">10.1016/S0168-8278(98)80182-7</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hind</surname><given-names>CR</given-names></name><name><surname>Wong</surname><given-names>CM</given-names></name></person-group><article-title>Detection of pulmonary arteriovenous fistulae in patients with cirrhosis by contrast 2D echocardiography</article-title><source>Gut</source><year>1981</year><volume>22</volume><fpage>1042</fpage><lpage>1045</lpage><pub-id pub-id-type="pmid">7319288</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>WE</given-names></name><name><surname>Waggoner</surname><given-names>AD</given-names></name><name><surname>Barzilai</surname><given-names>B</given-names></name></person-group><article-title>Frequency and significance of intrapulmonary right-to-left shunting in end stage liver disease</article-title><source>Am J Cardiol</source><year>1992</year><volume>70</volume><fpage>516</fpage><lpage>519</lpage><pub-id pub-id-type="pmid">1642191</pub-id><pub-id pub-id-type="doi">10.1016/0002-9149(92)91200-N</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolfe</surname><given-names>JD</given-names></name><name><surname>Tashkin</surname><given-names>DP</given-names></name><name><surname>Holly</surname><given-names>FE</given-names></name><name><surname>Brachman</surname><given-names>MB</given-names></name><name><surname>Genovesi</surname><given-names>MG</given-names></name></person-group><article-title>Detection of abnormal small pulmonary vascular channels by a quantitative radionuclide method</article-title><source>Am J Med</source><year>1997</year><volume>63</volume><fpage>746</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">930949</pub-id><pub-id pub-id-type="doi">10.1016/0002-9343(77)90161-9</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pacca</surname><given-names>R</given-names></name><name><surname>Maddukuri</surname><given-names>P</given-names></name><name><surname>Pandian</surname><given-names>NG</given-names></name><name><surname>Kuvin</surname><given-names>JT</given-names></name></person-group><article-title>Echocardiographic detection of intrapulmonary shunting in a patient with hepatopulmonary syndrome: case report and review of the literature</article-title><source>Echocardiography</source><year>2006</year><volume>23</volume><fpage>56</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">16412185</pub-id><pub-id pub-id-type="doi">10.1111/j.1540-8175.2006.00131.x</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Izquierdo</surname><given-names>V</given-names></name><name><surname>Gomez</surname><given-names>D</given-names></name><name><surname>Macias</surname><given-names>E</given-names></name><name><surname>Siurana</surname><given-names>R</given-names></name><name><surname>Pujol</surname><given-names>A</given-names></name><name><surname>Martinez d</surname><given-names>V</given-names></name></person-group><article-title>Hepatopulmonary syndrome and radionuclide lung perfusion imaging</article-title><source>Clin Nucl Med</source><year>1998</year><volume>23</volume><fpage>550</fpage><lpage>551</lpage><pub-id pub-id-type="pmid">9712400</pub-id><pub-id pub-id-type="doi">10.1097/00003072-199808000-00021</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>GA</given-names></name><name><surname>Nanda</surname><given-names>NC</given-names></name><name><surname>Dubovsky</surname><given-names>EV</given-names></name><name><surname>Krowka</surname><given-names>MJ</given-names></name><name><surname>Fallon</surname><given-names>MB</given-names></name></person-group><article-title>Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach</article-title><source>Gastroenterology</source><year>1998</year><volume>114</volume><fpage>305</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">9453490</pub-id><pub-id pub-id-type="doi">10.1016/S0016-5085(98)70481-0</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Roisin</surname><given-names>R</given-names></name><name><surname>Krowka</surname><given-names>MJ</given-names></name><name><surname>Herve</surname><given-names>P</given-names></name><name><surname>Fallon</surname><given-names>MB</given-names></name></person-group><article-title>Pulmonary-Hepatic vascular Disorders (PHD)</article-title><source>Eur Respir J</source><year>2004</year><volume>24</volume><fpage>861</fpage><lpage>880</lpage><pub-id pub-id-type="pmid">15516683</pub-id><pub-id pub-id-type="doi">10.1183/09031936.04.00010904</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hourani</surname><given-names>JM</given-names></name><name><surname>Bellany</surname><given-names>PE</given-names></name><name><surname>Tashkin</surname><given-names>DP</given-names></name><name><surname>Batra</surname><given-names>P</given-names></name><name><surname>Simmons</surname><given-names>MS</given-names></name></person-group><article-title>Pulmonary dysfunction in advanced liver disease: frequent occurrence of an abnormal diffusing capacity</article-title><source>Am J Med</source><year>1991</year><volume>60</volume><fpage>693</fpage><lpage>700</lpage><pub-id pub-id-type="pmid">1904192</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>PA</given-names></name><name><surname>Stoller</surname><given-names>JK</given-names></name></person-group><article-title>The hepatopulmonary syndrome</article-title><source>Ann Intern Med</source><year>1995</year><volume>122</volume><fpage>521</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">7872588</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schenk</surname><given-names>P</given-names></name><name><surname>Schoniger-Hekele</surname><given-names>M</given-names></name><name><surname>Fuhrmann</surname><given-names>V</given-names></name><name><surname>Madl</surname><given-names>C</given-names></name><name><surname>Silberhumer</surname><given-names>G</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name></person-group><article-title>Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis</article-title><source>Gastroenterology</source><year>2003</year><volume>125</volume><fpage>1042</fpage><lpage>1052</lpage><pub-id pub-id-type="pmid">14517788</pub-id><pub-id pub-id-type="doi">10.1016/S0016-5085(03)01207-1</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abrams</surname><given-names>GA</given-names></name><name><surname>Sanders</surname><given-names>MK</given-names></name><name><surname>Fallon</surname><given-names>MB</given-names></name></person-group><article-title>Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates</article-title><source>Liver Transpl</source><year>2002</year><volume>8</volume><fpage>391</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">11965585</pub-id><pub-id pub-id-type="doi">10.1053/jlts.2002.32252</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krowka</surname><given-names>M</given-names></name></person-group><article-title>Hepatopulmonary Syndrome and Liver Transplantation</article-title><source>Liver Transpl</source><year>2000</year><volume>6</volume><fpage>113</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">10648589</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>PA</given-names></name><name><surname>Stoller</surname><given-names>JK</given-names></name></person-group><article-title>The hepatopulmonary syndrome. Effect of liver transplantation</article-title><source>Clin Chest Med</source><year>1996</year><volume>17</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">8665784</pub-id><pub-id pub-id-type="doi">10.1016/S0272-5231(05)70302-6</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>KL</given-names></name><name><surname>Wiesner</surname><given-names>RH</given-names></name><name><surname>Krowka</surname><given-names>MJ</given-names></name></person-group><article-title>Natural history of hepatopulmonary syndrome: Impact of liver transplantation</article-title><source>Hepatology</source><year>2005</year><volume>41</volume><fpage>1122</fpage><lpage>1129</lpage><pub-id pub-id-type="pmid">15828054</pub-id><pub-id pub-id-type="doi">10.1002/hep.20658</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rydell</surname><given-names>R</given-names></name><name><surname>Hoffbauer</surname><given-names>FW</given-names></name></person-group><article-title>Multiple pulmonary arteriovenous fistulas in juvenile cirrhosis</article-title><source>Am J Med</source><year>1956</year><volume>21</volume><fpage>450</fpage><lpage>460</lpage><pub-id pub-id-type="pmid">13354635</pub-id><pub-id pub-id-type="doi">10.1016/0002-9343(56)90043-2</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hales</surname><given-names>MR</given-names></name></person-group><article-title>Multiple arteriovenous fistulas of the lungs</article-title><source>Am J Pathol</source><year>1956</year><volume>32</volume><fpage>927</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">13354716</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kinane</surname><given-names>TB</given-names></name><name><surname>Westra</surname><given-names>SJ</given-names></name></person-group><article-title>Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 31-2004. A four-year-old boy with hypoxemia</article-title><source>N Engl J Med</source><year>2004</year><volume>351</volume><fpage>1667</fpage><lpage>1675</lpage><pub-id pub-id-type="pmid">15483286</pub-id><pub-id pub-id-type="doi">10.1056/NEJMcpc049023</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Regev</surname><given-names>A</given-names></name><name><surname>Yeshurun</surname><given-names>M</given-names></name><name><surname>Rodriguez</surname><given-names>M</given-names></name><name><surname>Sagie</surname><given-names>A</given-names></name><name><surname>Neff</surname><given-names>GW</given-names></name><name><surname>Molina</surname><given-names>EG</given-names></name><name><surname>Schiff</surname><given-names>ER</given-names></name></person-group><article-title>Transient hepatopulmonary syndrome in a patient with acute hepatitis A</article-title><source>J Viral Hepat</source><year>2001</year><volume>8</volume><fpage>83</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">11155156</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2893.2001.00270.x</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krowka</surname><given-names>MJ</given-names></name><name><surname>Dickson</surname><given-names>ER</given-names></name><name><surname>Cortese</surname><given-names>DA</given-names></name></person-group><article-title>Hepatopulmonary syndrome. Clinical observations and lack of therapeutic response to somatostatin analogue</article-title><source>Chest</source><year>1993</year><volume>104</volume><fpage>515</fpage><lpage>521</lpage><pub-id pub-id-type="pmid">8101797</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teuber</surname><given-names>G</given-names></name><name><surname>Teupe</surname><given-names>C</given-names></name><name><surname>Dietrich</surname><given-names>CF</given-names></name><name><surname>Caspary</surname><given-names>WF</given-names></name><name><surname>Buhl</surname><given-names>R</given-names></name><name><surname>Zeuzem</surname><given-names>S</given-names></name></person-group><article-title>Pulmonary dysfunction in non-cirrhotic patients with chronic viral hepatitis</article-title><source>Eur J Intern Med</source><year>2002</year><volume>13</volume><fpage>311</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">12144910</pub-id><pub-id pub-id-type="doi">10.1016/S0953-6205(02)00066-3</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Babbs</surname><given-names>C</given-names></name><name><surname>Warnes</surname><given-names/></name><name><surname>Haboubi</surname><given-names>NY</given-names></name></person-group><article-title>Non-cirrhotic portal hypertension with hypoxemia</article-title><source>Gut</source><year>1988</year><volume>29</volume><fpage>129</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">3343007</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Roisin</surname><given-names>R</given-names></name><name><surname>Agusti</surname><given-names>AGN</given-names></name><name><surname>Roca</surname><given-names>J</given-names></name></person-group><article-title>The hepatopulmonary syndrome: new name, old complexities</article-title><source>Thorax</source><year>1992</year><volume>47</volume><fpage>897</fpage><lpage>902</lpage><pub-id pub-id-type="pmid">1465744</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Agusti</surname><given-names>AGN</given-names></name><name><surname>Roca</surname><given-names>J</given-names></name><name><surname>Bosch</surname><given-names>J</given-names></name><name><surname>Rodriguez-Roisin</surname><given-names>R</given-names></name></person-group><article-title>The lung in patient with cirrhosis</article-title><source>J Hepatol</source><year>1990</year><volume>10</volume><fpage>251</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">2185300</pub-id><pub-id pub-id-type="doi">10.1016/0168-8278(90)90061-U</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krowka</surname><given-names>MJ</given-names></name><name><surname>Cortese</surname><given-names>DA</given-names></name></person-group><article-title>Hepatopulmonary syndrome. Current concepts in diagnostic and therapeutic considerations</article-title><source>Chest</source><year>1994</year><volume>105</volume><fpage>1528</fpage><lpage>1537</lpage><pub-id pub-id-type="pmid">8181347</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>CJ</given-names></name><name><surname>Martin</surname><given-names>JF</given-names></name></person-group><article-title>Megakaryocytes and platelet clumps as the cause of finger clubbing</article-title><source>Lancet</source><year>1987</year><volume>ii</volume><fpage>1434</fpage><lpage>1435</lpage><pub-id pub-id-type="pmid">2891996</pub-id><pub-id pub-id-type="doi">10.1016/S0140-6736(87)91132-9</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>CJ</given-names></name></person-group><article-title>The aetiology of clubbing and hypertrophic osteoarthropathy</article-title><source>Eur J Clin Invest</source><year>1993</year><volume>23</volume><fpage>330</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">8344332</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>SB</given-names></name><name><surname>Day</surname><given-names>CA</given-names></name><name><surname>Gatter</surname><given-names>KC</given-names></name></person-group><article-title>Association between platelet microthrombi and finger clubbing</article-title><source>Lancet</source><year>1991</year><volume>338</volume><fpage>313</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">1677131</pub-id><pub-id pub-id-type="doi">10.1016/0140-6736(91)90452-U</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scott</surname><given-names>V</given-names></name><name><surname>Miro</surname><given-names>A</given-names></name><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>DeWolf</surname><given-names>A</given-names></name><name><surname>Bellary</surname><given-names>S</given-names></name><name><surname>Martin</surname><given-names>M</given-names></name><name><surname>Kramer</surname><given-names>D</given-names></name><name><surname>Selby</surname><given-names>R</given-names></name><name><surname>Doyle</surname><given-names>H</given-names></name><name><surname>Paradis</surname><given-names>I</given-names></name></person-group><article-title>Reversibility of the hepatopulmonary syndrome by orthotopic liver transplantation</article-title><source>Transplant Proc</source><year>1993</year><volume>25</volume><fpage>1787</fpage><lpage>1788</lpage><pub-id pub-id-type="pmid">8470165</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>SaO<sub>2 </sub>in HPS patients</bold>. SaO<sub>2 </sub>in the four HPS patients in supine and after 10 minutes in upright position.</p></caption><graphic xlink:href="1471-230X-6-15-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Correlation of Shunt Volume and SaO<sub>2</sub></bold>. Correlation between estimated shunt volume (perfusion lung scan) and arterial oxygen saturation (SaO<sub>2</sub>, R = -0.94) in four HPS patients.</p></caption><graphic xlink:href="1471-230X-6-15-2"/></fig><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Correlation of Shunt Volume and arterial pO<sub>2</sub></bold>. Correlation between estimated shunt volume (perfusion lung scan) and arterial pO<sub>2 </sub>in four HPS patients (R = -0.69).</p></caption><graphic xlink:href="1471-230X-6-15-3"/></fig><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Characteristics of the 316 Study Patients</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Variable</td><td></td></tr></thead><tbody><tr><td align="left">Mean Age* (yr)</td><td align="center">54.5 (12.9)</td></tr><tr><td align="left">Sex (M/F)</td><td align="center">194/122</td></tr><tr><td align="left">Etiology of liver disease [%]</td><td></td></tr><tr><td align="left">&#x02003;Alcohol</td><td align="center">51.2</td></tr><tr><td align="left">&#x02003;Hepatitis B virus</td><td align="center">15.2</td></tr><tr><td align="left">&#x02003;Hepatitis C virus</td><td align="center">22.2</td></tr><tr><td align="left">&#x02003;Hemochromatosis</td><td align="center">1.9</td></tr><tr><td align="left">&#x02003;Wilson's diesease</td><td align="center">0.6</td></tr><tr><td align="left">&#x02003;PBC</td><td align="center">1.9</td></tr><tr><td align="left">&#x02003;Autoimmune hepatitis</td><td align="center">2.8</td></tr><tr><td align="left">&#x02003;Unknown</td><td align="center">4.2</td></tr><tr><td align="left">Manifestation of liver disease [%]</td><td></td></tr><tr><td align="left">&#x02003;Chronic hepatitis (n = 69)</td><td align="center">21.8</td></tr><tr><td align="left">&#x02003;Liver cirrhosis (n = 245)</td><td align="center">77.5</td></tr><tr><td align="left">&#x02003;Non-cirrhotic portal hypertension (n = 2)</td><td align="center">0.6</td></tr><tr><td align="left">Liver cirrhosis classification [%]</td><td></td></tr><tr><td align="left">&#x02003;Child-Pugh-Stage A</td><td align="center">36.3</td></tr><tr><td align="left">&#x02003;B</td><td align="center">42.5</td></tr><tr><td align="left">&#x02003;C</td><td align="center">21.2</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Characteristics of the 4 Patients with HPS</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Age (yr)</td><td align="left">Gender</td><td align="left">Disease etiology</td><td align="center">SaO<sub>2 </sub>(%) supine</td><td align="center">SaO<sub>2 </sub>(%) upright</td><td align="center">pO<sub>2 </sub>(mmHg) upright</td><td align="center">Shunt volume (%)</td></tr></thead><tbody><tr><td align="left">62</td><td align="left">&#x02020;</td><td align="left">HCV-cirrhosis</td><td align="center">94</td><td align="center">90</td><td align="center">71</td><td align="center">7</td></tr><tr><td align="left">28</td><td align="left">&#x02642;</td><td align="left">Portal vein thrombosis</td><td align="center">84</td><td align="center">82</td><td align="center">54</td><td align="center">10</td></tr><tr><td align="left">27</td><td align="left">&#x02642;</td><td align="left">Chronic EBV-infection</td><td align="center">93</td><td align="center">78</td><td align="center">64</td><td align="center">28</td></tr><tr><td align="left">31</td><td align="left">&#x02642;</td><td align="left">Nodular regenerative hyperplasia</td><td align="center">90</td><td align="center">71</td><td align="center">36</td><td align="center">34</td></tr></tbody></table></table-wrap></sec></back></article>


